A cost-effectiveness analysis of RefluxStop against relevant therapeutic alternatives for chronic gastroesophageal reflux disease in Sweden
RefluxStop may offer a highly cost-effective long-term treatment alternative for chronic GERD patients over lifelong PPI therapy, but also in comparison with laparoscopic Nissen fundoplication.
Authors
- Muralikrishnan Radhakrishnan (ORCID: https://orcid.org/0000-0003-4380-3471)
- Stuart Mealing (ORCID: https://orcid.org/0000-0002-2564-1440)
- Sam Harper (ORCID: https://orcid.org/0000-0002-2767-1053)
- Lars Lundell
Institutions
- Odense University Hospital (DK)
- Leeds and York Partnership NHS Foundation Trust (GB)
- Karolinska Institutet (SE)
- Implantica (Switzerland) (CH)
- University of York (GB)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2024-10-20
- DOI
- https://doi.org/10.1080/14737167.2024.2417774
- Citations
- 3
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39